On June 14, 2021 CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, reported that management will participate in three virtual investor conferences including SVB Leerink CybeRx Series: "Liver Disease Day" Conference taking place June 17, 2021, the Raymond James Human Health Innovation Conference taking place June 22, 2021 and the Piper Sandler "EASL Takeaway Day" taking place June 28, 2021 (Press release, CymaBay Therapeutics, JUN 14, 2021, View Source [SID1234583952]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

SVB Leerink CybeRx Series: "Liver Disease Day" Conference
Date: Thursday, June 17
Time: 1-on-1 meetings only

Raymond James Human Health Innovation Conference
Date: Monday, June 21
Time: 9:20 am Eastern Time
Panel Discussion: "Itching for New Therapies in Cholestatic Liver Disease"

Piper Sandler "EASL Takeaway Day"
Date: Monday, June 28
Time: 3:00 pm Eastern Time / Fireside Chat
Webcast: View Source